We are live on ! Find out more
Cowen and Company

Cowen and Company Portfolio holdings

AUM $2.97B Turnover 45.91%
1-Year Est. Return 105.25%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.25%
3 Year Est. Return
+120.04%
5 Year Est. Return
+670.5%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
-$746M
Cap. Flow %
-25.14%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVDA icon
1
NVIDIA
NVDA
$3.61T
$675M 22.74%
5,559,626
-245,742
-4% -$29M
2023 Q2
5 quarters
COIN icon
2
Coinbase
COIN
$29.6B
$227M 7.65%
1,275,333
-213,642
-14% -$42.8M
2022 Q3
8 quarters
META icon
3
Meta Platforms (Facebook)
META
$1.55T
$177M 5.97%
309,820
-463,835
-60% -$239M
2022 Q4
7 quarters
AMZN icon
4
Amazon
AMZN
$2.84T
$143M 4.83%
769,822
+90,736
+13% +$16.6M
2024 Q1
2 quarters
MSFT icon
5
Microsoft
MSFT
$3.77T
$141M 4.74%
327,257
+280,640
+602% +$120M
2024 Q1
2 quarters
PTCT icon
6
PTC Therapeutics
PTCT
$4.96B
$133M 4.49%
3,590,655
-165,814
-4% -$5.55M
2023 Q2
5 quarters
AAPL icon
7
Apple
AAPL
$5.07T
$122M 4.11%
523,959
-820,528
-61% -$183M
2022 Q2
9 quarters
LLY icon
8
Eli Lilly
LLY
$1.21T
$116M 3.89%
+130,399
New +$117M
2024 Q3
0 quarters
TSLA icon
9
Tesla
TSLA
$1.5T
$80.7M 2.72%
308,553
+69,169
+29% +$15.8M
2024 Q2
1 quarter
TARS icon
10
Tarsus Pharmaceuticals
TARS
$3.83B
$72.3M 2.43%
2,197,385
– –
2023 Q2
5 quarters
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$3.47T
$69.5M 2.34%
+419,077
New +$70.3M
2024 Q3
0 quarters
BABA icon
12
Alibaba
BABA
$212B
$67M 2.26%
631,199
+106,573
+20% +$8.72M
2022 Q4
7 quarters
AMD icon
13
Advanced Micro Devices
AMD
$806B
$52M 1.75%
317,107
-650,124
-67% -$98.8M
2024 Q1
2 quarters
STOK icon
14
Stoke Therapeutics
STOK
$1.77B
$39.9M 1.34%
3,244,498
-121,246
-4% -$1.72M
2021 Q3
12 quarters
ESTA icon
15
Establishment Labs
ESTA
$2.09B
$37.6M 1.27%
869,948
-70,000
-7% -$3.04M
2019 Q4
19 quarters
NKLA icon
16
PUT
DELISTED
Nikola
NKLA
$33.7M 1.14%
1,245,900
+841,000
+208% +$6.23M
2024 Q1
2 quarters
ET icon
17
Energy Transfer
ET
$65.6B
$30.4M 1.03%
1,897,000
+70,000
+4% +$1.13M
2021 Q4
11 quarters
ANSC
18
DELISTED
Agriculture & Natural Solutions Acquisition Corp
ANSC
$23.3M 0.78%
2,246,381
+272,702
+14% +$2.81M
2024 Q1
2 quarters
URGN icon
19
UroGen Pharma
URGN
$1.57B
$22.8M 0.77%
1,796,589
-302,893
-14% -$4.5M
2024 Q1
2 quarters
MERC icon
20
Mercer International
MERC
$11.5M
$22.3M 0.75%
3,300,000
– –
2023 Q2
5 quarters
KDK icon
21
Kodiak AI
KDK
$210M
$21.3M 0.72%
1,963,091
-1,345,140
-41% -$14.5M
2023 Q2
5 quarters
RCKT icon
22
Rocket Pharmaceuticals
RCKT
$234M
$20.3M 0.68%
1,100,000
– –
2021 Q2
13 quarters
SMFG icon
23
Sumitomo Mitsui Financial Group
SMFG
$144B
$19.7M 0.66%
1,560,230
-1,240,500
-44% -$16.4M
2024 Q1
2 quarters
PLTR icon
24
Palantir
PLTR
$377B
$19.5M 0.66%
+523,644
New +$16.1M
2024 Q3
0 quarters
STHO icon
25
Star Holdings Shares of Beneficial Interest
STHO
$89M
$18.3M 0.62%
1,324,301
+4,705
+0.4% +$61K
2023 Q4
3 quarters

Similar funds

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company withdrew a net $746M in Q3 2024, closing 179 positions and reducing 157 holdings. Its most notable exit was Avidity Biosciences, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Cowen and Company opened a new position in Eli Lilly worth $116M.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.